Showing results (341-350 of 635) with videos related to
Sort By:
Pageof 64
European Journal of Heart Failure|May 16, 2023
Incremental prognostic value of biomarkers in PARADIGM-HFKirsty McDowell, Ross Campbell, Joanne Simpson, et al.Journal of the American College of Cardiology|April 17, 2026
Interchangeability of the KCCQ-12 and KCCQ-23 Across >18,000 Participants Enrolled in 4 Large-Scale Trials of Heart FailureYasuhiro Hamatani, Brian L Claggett, Akshay S Desai, et al.Scientific Reports|November 29, 2023
Opportunistic assessment of ischemic heart disease risk using abdominopelvic computed tomography and medical record data: a multimodal explainable artificial intelligence approachJuan M Zambrano Chaves, Andrew L Wentland, Arjun D Desai, et al.The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.Journal of the American College of Cardiology|November 15, 2019
Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared With Valsartan in HFpEFMuthiah Vaduganathan, Brian L Claggett, Akshay S Desai, et al.Journal of Cardiac Failure|June 9, 2019
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of AmericaShannon M Dunlay, Michael M Givertz, David Aguilar, et al.Circulation. Heart Failure|May 28, 2026
Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HFAkshay S Desai, Michael R Zile, Anique Ducharme, et al.The Lancet. Diabetes & Endocrinology|March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trialJelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.Circulation|June 7, 2019
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline updateShannon M Dunlay, Michael M Givertz, David Aguilar, et al.Circulation. Heart Failure|March 21, 2023
Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF TrialJawad H Butt, Wasyla Ibrahim, Pooja Dewan, et al.Pageof 64